Therefore, understanding the epigenetic mechanisms that control the methylation of proteins responsible for DNA repair after IR (including BRCA1) could be important to design therapies that avoid the resistance of tumor cells to radiotherapy. The gene discussed is BRCA1; the disease is neoplasm.